Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
Saved in:
Warden, D., ET AL., Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. Addictive Behaviors, Vol. 37, no. 9 (2012), p. 1046-1053.
Ref.
190644
Location:
SIIS R.992 Archivo
Palabras clave:
Alternativas, Buprenorfina, Drogas ilegales, Drogodependencias, Factor de protección, Factor de riesgo, Fármacos, Juventud, Opiáceos, Predicción, Programas de mantenimiento, Recaída, Reducción de daños, Retención, Tratamiento médico
Alternativas, Buprenorfina, Drogas ilegales, Drogodependencias, Factor de protección, Factor de riesgo, Fármacos, Juventud, Opiáceos, Predicción, Programas de mantenimiento, Recaída, Reducción de daños, Retención, Tratamiento médico
Similar Items: Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
- PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
- ANTIDEPRESSANT TREATMENT DOES NOT IMPROVE BUPRENORPHINE RETENTION AMONG OPIOID DEPENDENT PERSONS
- PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK